The reiteration of a Buy rating and the maintenance of a $12 price target by a reputable analyst firm like HC Wainwright & Co. could positively influence investor sentiment towards Anixa Biosciences. This endorsement reaffirms the firm's confidence in ANIX's potential, likely leading to increased investor interest and potentially a positive impact on the stock's short-term price movement.